Trials / Completed
CompletedNCT00678899
Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant System
Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Cochlear · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy associated with the provision of acoustic and electric sound processing to individuals who demonstrate significant residual low-frequency hearing and profound high-frequency (above 1500 Hz) sensorineural hearing loss. Delivery of acoustic-electric stimulation will be provided by the Nucleus Hybrid L24 cochlear implant system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Nucleus Hybrid L24 | Implantation with Nucleus Hybrid L24 cochlear implant |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2012-06-01
- Completion
- 2014-07-01
- First posted
- 2008-05-16
- Last updated
- 2015-07-15
- Results posted
- 2014-09-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00678899. Inclusion in this directory is not an endorsement.